SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-20-014558
Filing Date
2020-12-29
Accepted
2020-12-29 16:17:41
Documents
14
Period of Report
2020-12-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ampe-20201229x8k.htm   iXBRL 8-K 31487
2 EX-99.1 ampe-20201229xex99d1.htm EX-99.1 12233
3 GRAPHIC ampe-20201229xex99d1001.jpg GRAPHIC 2352
  Complete submission text file 0001558370-20-014558.txt   168811

Data Files

Seq Description Document Type Size
4 EX-101.SCH ampe-20201229.xsd EX-101.SCH 3273
5 EX-101.LAB ampe-20201229_lab.xml EX-101.LAB 15501
6 EX-101.PRE ampe-20201229_pre.xml EX-101.PRE 10516
7 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20201229x8k_htm.xml XML 4728
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35182 | Film No.: 201422527
SIC: 2834 Pharmaceutical Preparations